Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
17.50M | 19.35M | 18.27M | 12.54M | 11.98M | 11.96M | Gross Profit |
1.90M | 2.94M | -4.22M | 2.69M | 4.82M | 2.28M | EBIT |
1.90M | 0.00 | -9.64M | -4.81M | -3.32M | -16.63M | EBITDA |
697.13K | 313.67K | -10.03M | -13.83M | -2.71M | -14.26M | Net Income Common Stockholders |
-889.79K | -1.14M | -13.36M | -18.07M | -6.29M | -20.02M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
318.57K | 449.18K | 1.09M | 363.27K | 4.41M | 2.76M | Total Assets |
17.05M | 16.87M | 18.02M | 29.01M | 45.35M | 46.58M | Total Debt |
17.79M | 16.78M | 17.57M | 17.68M | 17.87M | 25.74M | Net Debt |
17.47M | 16.33M | 16.48M | 17.32M | 13.47M | 22.98M | Total Liabilities |
22.61M | 21.70M | 23.28M | 21.49M | 20.12M | 27.13M | Stockholders Equity |
-4.41M | -3.53M | -3.69M | 8.52M | 25.99M | 20.36M |
Cash Flow | Free Cash Flow | ||||
1.20M | 801.71K | -2.33M | -5.10M | -5.12M | -16.07M | Operating Cash Flow |
1.69M | 1.69M | -1.53M | -5.09M | -4.67M | -14.98M | Investing Cash Flow |
-381.39K | -890.78K | 2.33M | 1.58K | -456.36K | -1.24M | Financing Cash Flow |
-1.48M | -1.46M | -266.55K | 1.53M | 6.06M | 1.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
53 Neutral | $5.25B | 3.24 | -45.38% | 2.81% | 16.79% | -0.06% | |
44 Neutral | C$2.45M | ― | ― | -9.20% | 93.62% | ||
C$1.96M | ― | ― | ― | ― | |||
$2.40M | ― | ― | ― | ― | |||
$1.94M | ― | ― | ― | ― | |||
40 Underperform | C$2.79M | ― | -21.61% | ― | ― | ― | |
39 Underperform | C$1.34M | ― | -178.36% | ― | 0.89% | -179.36% |
Zentek Ltd. has announced a US$30 million at-the-market offering in the United States, with Rodman & Renshaw LLC as the exclusive sales agent. The offering will be conducted on Nasdaq and other U.S. marketplaces, with proceeds intended for corporate purposes. This move is expected to enhance Zentek’s financial flexibility and support its growth strategy.
1933 Industries reported its first quarter financial results for 2025, showing a revenue of $4.0 million, a decrease from the previous year’s $5.2 million, attributed to soft sales and declining flower prices in Nevada. Despite a net loss of $0.6 million, the company maintained a strong market position, ranking third in cannabis sales in Nevada, reflecting its continued influence in the market despite economic challenges.